Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Girard

Showing results (131-140 of 396) with videos related to

Pageof 40
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 12, 2017
Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial TumorsAlexandra Meurgey, Nicolas Girard, Claire Merveilleux du Vignaux, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2021
Lymph Node Dissection in Thymoma: Is it worth it?Hugo Clermidy, Jean-Michel Maury, Stéphane Collaud, et al.
Nature Reviews. Clinical Oncology|July 28, 2018
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyLuc Cabel, Charlotte Proudhon, Emanuela Romano, et al.
Lung Cancer (Amsterdam, Netherlands)|November 3, 2009
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trialNicolas Girard, Françoise Mornex, Jean-Yves Douillard, et al.
JTO Clinical and Research Reports|July 31, 2025
Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic CarcinomaChul Kim, Vanya Aggarwal, Gedske Daugaard, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC networkJordi Remon, Nicolas Girard, Julien Mazieres, et al.
Respiratory Medicine and Research|June 12, 2023
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapyClarisse Audigier Valette, Thomas Filleron, Didier Debieuvre, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2026
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityGerrina Ruiter, Xiuning Le, Ross A Soo, et al.
International Journal of Molecular Sciences|February 25, 2023
Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung CancerClémence Basse, Olfa Trabelsi-Grati, Julien Masliah, et al.
Archives of Pathology & Laboratory Medicine|August 8, 2019
Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic PracticeNolwenn Le Stang, Louise Burke, Gaetane Blaizot, et al.
Pageof 40

Showing results (131-140 of 396) with videos related to

Sort By:
Pageof 40
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 12, 2017
Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial TumorsAlexandra Meurgey, Nicolas Girard, Claire Merveilleux du Vignaux, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2021
Lymph Node Dissection in Thymoma: Is it worth it?Hugo Clermidy, Jean-Michel Maury, Stéphane Collaud, et al.
Nature Reviews. Clinical Oncology|July 28, 2018
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapyLuc Cabel, Charlotte Proudhon, Emanuela Romano, et al.
Lung Cancer (Amsterdam, Netherlands)|November 3, 2009
Is neoadjuvant chemoradiotherapy a feasible strategy for stage IIIA-N2 non-small cell lung cancer? Mature results of the randomized IFCT-0101 phase II trialNicolas Girard, Françoise Mornex, Jean-Yves Douillard, et al.
JTO Clinical and Research Reports|July 31, 2025
Parallel Phase II Clinical Trials of Selinexor in Patients With Advanced Thymoma and Thymic CarcinomaChul Kim, Vanya Aggarwal, Gedske Daugaard, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2016
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC networkJordi Remon, Nicolas Girard, Julien Mazieres, et al.
Respiratory Medicine and Research|June 12, 2023
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapyClarisse Audigier Valette, Thomas Filleron, Didier Debieuvre, et al.
Lung Cancer (Amsterdam, Netherlands)|April 3, 2026
Emerging treatment strategies for HER2-mutant NSCLC: Striving for selectivity, efficacy, and tolerabilityGerrina Ruiter, Xiuning Le, Ross A Soo, et al.
International Journal of Molecular Sciences|February 25, 2023
Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung CancerClémence Basse, Olfa Trabelsi-Grati, Julien Masliah, et al.
Archives of Pathology & Laboratory Medicine|August 8, 2019
Differential Diagnosis of Epithelioid Malignant Mesothelioma With Lung and Breast Pleural Metastasis: A Systematic Review Compared With a Standardized Panel of Antibodies-A New Proposal That May Influence Pathologic PracticeNolwenn Le Stang, Louise Burke, Gaetane Blaizot, et al.
Pageof 40